Lupus Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lupus stocks.

Lupus Stocks Recent News

Date Stock Title
Nov 21 RNAC Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit
Nov 21 RNAC Timothy Springer Bought 4.9% More Shares In Cartesian Therapeutics
Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
Nov 19 ALDX ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
Nov 19 RIGL How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28%
Nov 19 RIGL Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive
Nov 19 BIIB Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
Nov 18 AUPH Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Nov 18 RIGL 5 Relative Price Strength Options Available for Investors
Nov 18 BIIB Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
Nov 18 ALDX Aldeyra announces FDA acceptance of resubmitted reproxalap application
Nov 18 BIIB Needham downgrades Biogen on slow growth of Alzheimer's drug
Nov 18 BIIB Biogen cut to hold by Needham on lack of catalysts, slow Leqembi sales
Nov 18 XNCR Wall Street Analysts Believe Xencor (XNCR) Could Rally 53.53%: Here's is How to Trade
Nov 18 BIIB Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™
Nov 18 ALDX Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
Nov 18 BIIB Is Biogen Inc. (BIIB) A Cheap NASDAQ Stock To Invest In Now?
Nov 17 KYTX institutional investors of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) must be disappointed after last week's 18% drop
Lupus

Systemic lupus erythematosus (SLE), also known simply as lupus, is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. Symptoms vary between people and may be mild to severe. Common symptoms include painful and swollen joints, fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, feeling tired, and a red rash which is most commonly on the face. Often there are periods of illness, called flares, and periods of remission during which there are few symptoms.The cause of SLE is not clear. It is thought to involve genetics together with environmental factors. Among identical twins, if one is affected there is a 24% chance the other one will be as well. Female sex hormones, sunlight, smoking, vitamin D deficiency, and certain infections, are also believed to increase the risk. The mechanism involves an immune response by autoantibodies against a person's own tissues. These are most commonly anti-nuclear antibodies and they result in inflammation. Diagnosis can be difficult and is based on a combination of symptoms and laboratory tests. There are a number of other kinds of lupus erythematosus including discoid lupus erythematosus, neonatal lupus, and subacute cutaneous lupus erythematosus.There is no cure for SLE. Treatments may include NSAIDs, corticosteroids, immunosuppressants, hydroxychloroquine, and methotrexate. Alternative medicine has not been shown to affect the disease. Life expectancy is lower among people with SLE. SLE significantly increases the risk of cardiovascular disease with this being the most common cause of death. With modern treatment about 80% of those affected survive more than 15 years. Women with lupus have pregnancies that are higher risk but are mostly successful.Rate of SLE varies between countries from 20 to 70 per 100,000. Women of childbearing age are affected about nine times more often than men. While it most commonly begins between the ages of 15 and 45, a wide range of ages can be affected. Those of African, Caribbean, and Chinese descent are at higher risk than white people. Rates of disease in the developing world are unclear. Lupus is Latin for "wolf": the disease was so-named in the 13th century as the rash was thought to appear like a wolf's bite.

Browse All Tags